Pharmaceuticals

Hyperpigmentation Disorder Treatment Market was valued at US$ 6.67 Billion in 2022 and is expected to reach to US$ 11.78 Billion by 2030; it is estimated to record a CAGR of 7.4% from 2022 to 2030

• Pharmaceuticals

Hyperpigmentation Disorder Treatment Market was valued at US$ 6.67 Billion in 2022 and is expected to reach to US$ 11.78 Billion by 2030; it is estimated to record a CAGR of 7.4% from 2022 to 2030

Market News Insights October 11, 2024

Geographically, the global hyperpigmentation disorder treatment market is segmented into North America, Asia Pacific, Europe, the Middle...

Read More Read more about Hyperpigmentation Disorder Treatment Market was valued at US$ 6.67 Billion in 2022 and is expected to reach to US$ 11.78 Billion by 2030; it is estimated to record a CAGR of 7.4% from 2022 to 2030

Hospital Acquired Infection Treatment Market was valued at US$ 15,099.19 Million in 2022 and is expected to reach to US$ 19,978.39 Million by 2030; it is estimated to record a CAGR of 3.6% from 2022 to 2030

• Pharmaceuticals

Hospital Acquired Infection Treatment Market was valued at US$ 15,099.19 Million in 2022 and is expected to reach to US$ 19,978.39 Million by 2030; it is estimated to record a CAGR of 3.6% from 2022 to 2030

Market News Insights October 10, 2024

Asia Pacific is the fastest-growing market for hospital acquired infection treatment. North America accounted for the largest...

Read More Read more about Hospital Acquired Infection Treatment Market was valued at US$ 15,099.19 Million in 2022 and is expected to reach to US$ 19,978.39 Million by 2030; it is estimated to record a CAGR of 3.6% from 2022 to 2030

Fluorine-18 Market was valued at US$ 1.72 Billion in 2022 and is expected to reach to US$ 2.41 Billion by 2030; it is estimated to record a CAGR of 4.3% from 2022 to 2030

• Pharmaceuticals

Fluorine-18 Market was valued at US$ 1.72 Billion in 2022 and is expected to reach to US$ 2.41 Billion by 2030; it is estimated to record a CAGR of 4.3% from 2022 to 2030

Market News Insights October 8, 2024

Factors such as the heightened prevalence of chronic diseases and increasing use of nuclear imaging techniques propel...

Read More Read more about Fluorine-18 Market was valued at US$ 1.72 Billion in 2022 and is expected to reach to US$ 2.41 Billion by 2030; it is estimated to record a CAGR of 4.3% from 2022 to 2030

Malaria Treatment Market was valued at US$ 3,296.98 Million in 2022 and is expected to reach to US$ 24,487.73 Million by 2030; it is estimated to record a CAGR of 28.5% from 2022 to 2030

• Pharmaceuticals

Malaria Treatment Market was valued at US$ 3,296.98 Million in 2022 and is expected to reach to US$ 24,487.73 Million by 2030; it is estimated to record a CAGR of 28.5% from 2022 to 2030

Market News Insights October 4, 2024

Extending Pipeline of New Drugs and Vaccines Antimicrobial resistance can put the public at risk of many...

Read More Read more about Malaria Treatment Market was valued at US$ 3,296.98 Million in 2022 and is expected to reach to US$ 24,487.73 Million by 2030; it is estimated to record a CAGR of 28.5% from 2022 to 2030

Monoclonal Antibody Therapeutics (mABs) Market was valued at US$ 192.04 Billion in 2022 and is expected to reach to US$ 542.80 Billion by 2030; it is estimated to record a CAGR of 13.9% from 2022 to 2030

• Pharmaceuticals

Monoclonal Antibody Therapeutics (mABs) Market was valued at US$ 192.04 Billion in 2022 and is expected to reach to US$ 542.80 Billion by 2030; it is estimated to record a CAGR of 13.9% from 2022 to 2030

Market News Insights October 3, 2024

Production of mAB-Based Drugs to Treat Several Diseases Drives Market Growth Monoclonal antibody therapeutics (mABs) are employed...

Read More Read more about Monoclonal Antibody Therapeutics (mABs) Market was valued at US$ 192.04 Billion in 2022 and is expected to reach to US$ 542.80 Billion by 2030; it is estimated to record a CAGR of 13.9% from 2022 to 2030

Myopia Treatment Market was valued at US$ 10,276.67 Million in 2022 and is expected to reach to US$ 19,571.85 Million by 2030; it is estimated to record a CAGR of 8.39% from 2022 to 2030

• Pharmaceuticals

Myopia Treatment Market was valued at US$ 10,276.67 Million in 2022 and is expected to reach to US$ 19,571.85 Million by 2030; it is estimated to record a CAGR of 8.39% from 2022 to 2030

Market News Insights October 1, 2024

North America accounted for the largest share of the global myopia treatment market in 2022. The market...

Read More Read more about Myopia Treatment Market was valued at US$ 10,276.67 Million in 2022 and is expected to reach to US$ 19,571.85 Million by 2030; it is estimated to record a CAGR of 8.39% from 2022 to 2030

Microbiome Therapeutics Market was valued at US$ 375.92 Million in 2022 and is expected to reach US$ 813.38 Million by 2030; it is estimated to record a CAGR of 10.1% from 2022 to 2030

• Life Sciences
• Pharmaceuticals

Microbiome Therapeutics Market was valued at US$ 375.92 Million in 2022 and is expected to reach US$ 813.38 Million by 2030; it is estimated to record a CAGR of 10.1% from 2022 to 2030

Market News Insights September 27, 2024

The potential of gut microbiota in maintaining human health and inflow of funds to ameliorate microbiome discovery...

Read More Read more about Microbiome Therapeutics Market was valued at US$ 375.92 Million in 2022 and is expected to reach US$ 813.38 Million by 2030; it is estimated to record a CAGR of 10.1% from 2022 to 2030

Empty Capsules Market was valued at US$ 6.75 Billion in 2022 and is expected to reach to US$ 12.52 Billion by 2030; it is estimated to record a CAGR of 8.0% from 2022 to 2030

• Pharmaceuticals

Empty Capsules Market was valued at US$ 6.75 Billion in 2022 and is expected to reach to US$ 12.52 Billion by 2030; it is estimated to record a CAGR of 8.0% from 2022 to 2030

Market News Insights September 26, 2024

Empty capsules are made of gelatin, hydroxypropyl methylcellulose (HPMC), pullulan, and starch. These capsules can be used...

Read More Read more about Empty Capsules Market was valued at US$ 6.75 Billion in 2022 and is expected to reach to US$ 12.52 Billion by 2030; it is estimated to record a CAGR of 8.0% from 2022 to 2030

Drug Discovery Services Market was valued at US$ 19,539.00 million in 2022 and is expected to reach to US$ 56,783.29 million by 2030; it is estimated to record a CAGR of 14.3% from 2022 to 2030

• Pharmaceuticals

Drug Discovery Services Market was valued at US$ 19,539.00 million in 2022 and is expected to reach to US$ 56,783.29 million by 2030; it is estimated to record a CAGR of 14.3% from 2022 to 2030

Market News Insights September 20, 2024

Increasing demand for novel therapies across a wide range of therapeutic areas, and rising R&D expenditure in...

Read More Read more about Drug Discovery Services Market was valued at US$ 19,539.00 million in 2022 and is expected to reach to US$ 56,783.29 million by 2030; it is estimated to record a CAGR of 14.3% from 2022 to 2030

Malaria And Sickle Cell Disease Treatment Market was valued at US$ 4,457.15 Million in 2022 and is expected to reach US$ 29,179.60 Million by 2030; it is estimated to record a CAGR of 26.5% from 2022 to 2030

• Life Sciences
• Pharmaceuticals

Malaria And Sickle Cell Disease Treatment Market was valued at US$ 4,457.15 Million in 2022 and is expected to reach US$ 29,179.60 Million by 2030; it is estimated to record a CAGR of 26.5% from 2022 to 2030

Market News Insights September 18, 2024

Asia Pacific is the fastest-growing region in the global malaria and sickle cell disease treatment market. North...

Read More Read more about Malaria And Sickle Cell Disease Treatment Market was valued at US$ 4,457.15 Million in 2022 and is expected to reach US$ 29,179.60 Million by 2030; it is estimated to record a CAGR of 26.5% from 2022 to 2030